West Pharmaceutical Services, Inc.
WST Healthcare Medical Instruments & Supplies
West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow WST
West Pharmaceutical Services, Inc. (WST) Revenue growth
West Pharmaceutical Services, Inc.'s revenue growth over the twelve months to 30 June 2026 was 12.4%, up 6.1 percentage points from fiscal 2025 (6.25%). Over the past ten years it has ranged from −1.92% (fiscal 2024) to 31.9% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Medical Instruments & Supplies industry median of 8.85% and above the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 6.25% | 8.17 |
| FY2024 | −1.92% | (4.10) |
| FY2023 | 2.18% | 0.23 |
| FY2022 | 1.95% | (29.94) |
| FY2021 | 31.9% | 15.20 |
| FY2020 | 16.7% | 9.56 |
| FY2019 | 7.13% | (0.27) |
| FY2018 | 7.40% | 1.44 |
| FY2017 | 5.96% | (1.85) |
| FY2016 | 7.81% | 9.33 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 13.8% | (7.25) |
| Mar 2026 | 21.1% | 13.54 |
| Dec 2025 | 7.51% | (0.22) |
| Sep 2025 | 7.73% | (1.44) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| RGEN Repligen Corporation compare | 16.5% |
| BDX Becton, Dickinson and Company compare | 13.1% |
| WST West Pharmaceutical Services, Inc. | 12.4% |
| RMD ResMed Inc. compare | 9.85% |
| ALC Alcon compare | 8.34% |
| BAX Baxter International Inc. compare | 5.36% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| SOLV Solventum Corporation compare | −0.93% |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.85% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on WST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement